Autolus Therapeutics plc — Form SCHEDULE 13D/A
Filed August 28, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 18/100
What the filing says
PPF IM Ltd., Renata Kellnerova, Amalar Holding S.R.O., and PPF Group A.S. executed an amended and restated joint filing agreement on August 27, 2026, regarding their beneficial ownership of Autolus Therapeutics plc securities exceeding 5%. The filing also includes a power of attorney naming Lubomír Králí and Radomír Johanna as agents to execute Forms 3, 4, 5 and Schedules 13D/13G. No specific shareholding percentages, share counts, or ownership changes are disclosed in this procedural amendment.
Why this rating
Administrative SEC filing updating joint filing agreements and POA. No ownership stakes, share counts, or transaction details disclosed. Procedural document only.
See more from August 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.